Despite making up over 80% of the world’s population and more than 90% of its disease burden, low- and middle-income countries (LMICs) have suffered the most from global health disparities for far too long. Despite this, they only account for 6% of global pharmaceutical revenue. Getting everyone access to high-quality, low-cost drugs is still hard, but it’s more important than ever to solve this problem.

Today, Axmed, an innovative two-sided B2B marketplace platform, announced a $2 million seed funding round. This is a significant step towards solving this problem. This investment aims to speed up the process of making essential and new medicines more affordable, available, and sent to areas that need them.
Read the full story via the link below
https://techpression.com/from-seed-to-success-axmeds-2m-funding